103 related articles for article (PubMed ID: 8977329)
1. Migratory response of human natural killer cells to lymphotactin.
Giancarlo B; Silvano S; Albert Z; Mantovani A; Allavena P
Eur J Immunol; 1996 Dec; 26(12):3238-41. PubMed ID: 8977329
[TBL] [Abstract][Full Text] [Related]
2. Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo.
Hedrick JA; Saylor V; Figueroa D; Mizoue L; Xu Y; Menon S; Abrams J; Handel T; Zlotnik A
J Immunol; 1997 Feb; 158(4):1533-40. PubMed ID: 9029087
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin.
Huang H; Li F; Cairns CM; Gordon JR; Xiang J
Biochem Biophys Res Commun; 2001 Feb; 281(2):378-82. PubMed ID: 11181058
[TBL] [Abstract][Full Text] [Related]
4. Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100.
Xia DJ; Zhang WP; Zheng S; Wang J; Pan JP; Wang Q; Zhang LH; Hamada H; Cao X
Gene Ther; 2002 May; 9(9):592-601. PubMed ID: 11973635
[TBL] [Abstract][Full Text] [Related]
5. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
[TBL] [Abstract][Full Text] [Related]
6. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.
Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J
J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111
[TBL] [Abstract][Full Text] [Related]
7. Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis.
Taub DD; Sayers TJ; Carter CR; Ortaldo JR
J Immunol; 1995 Oct; 155(8):3877-88. PubMed ID: 7561094
[TBL] [Abstract][Full Text] [Related]
8. Regulation of adhesion and transendothelial migration of natural killer cells.
Allavena P; Bianchi G; Paganin C; Giardina G; Mantovani A
Nat Immun; 1996-1997; 15(2-3):107-16. PubMed ID: 9162261
[TBL] [Abstract][Full Text] [Related]
9. Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12.
Hennemann B; Tam YK; Tonn T; Klingemann HG
DNA Cell Biol; 1999 Jul; 18(7):565-71. PubMed ID: 10433555
[TBL] [Abstract][Full Text] [Related]
10. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
Huang H; Li F; Gordon JR; Xiang J
Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
[TBL] [Abstract][Full Text] [Related]
11. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins.
Maghazachi AA; al-Aoukaty A; Schall TJ
J Immunol; 1994 Dec; 153(11):4969-77. PubMed ID: 7525719
[TBL] [Abstract][Full Text] [Related]
12. Expression of activation-induced, T cell-derived, and chemokine-related cytokine/lymphotactin and its functional role in rheumatoid arthritis.
Blaschke S; Middel P; Dorner BG; Blaschke V; Hummel KM; Kroczek RA; Reich K; Benoehr P; Koziolek M; Müller GA
Arthritis Rheum; 2003 Jul; 48(7):1858-72. PubMed ID: 12847680
[TBL] [Abstract][Full Text] [Related]
13. The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4(+) T cells.
Cerdan C; Serfling E; Olive D
Blood; 2000 Jul; 96(2):420-8. PubMed ID: 10887101
[TBL] [Abstract][Full Text] [Related]
14. Lymphotactin acts as an innate mucosal adjuvant.
Lillard JW; Boyaka PN; Hedrick JA; Zlotnik A; McGhee JR
J Immunol; 1999 Feb; 162(4):1959-65. PubMed ID: 9973465
[TBL] [Abstract][Full Text] [Related]
15. Migration of natural killer cells across endothelial cell monolayers.
Bianchi G; Sironi M; Ghibaudi E; Selvaggini C; Elices M; Allavena P; Mantovani A
J Immunol; 1993 Nov; 151(10):5135-44. PubMed ID: 7693804
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFA-1 antibody.
Van Epps DE; Potter J; Vachula M; Smith CW; Anderson DC
J Immunol; 1989 Nov; 143(10):3207-10. PubMed ID: 2681413
[TBL] [Abstract][Full Text] [Related]
18. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
Chen WS; Kitson RP; Goldfarb RH
In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
[TBL] [Abstract][Full Text] [Related]
19. Anti-Gal IgG potentiates natural killer cell migration across porcine endothelium via endothelial cell activation and increased natural killer cell motility triggered by CD16 cross-linking.
Hauzenberger E; Klominek J; Holgersson J
Eur J Immunol; 2004 Apr; 34(4):1154-63. PubMed ID: 15048727
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
